Literature DB >> 1974174

Autoantibodies against peripheral blood cells appear early in HIV infection and their prevalence increases with disease progression.

R J Klaassen1, J W Mulder, A B Vlekke, J K Eeftinck Schattenkerk, H M Weigel, J M Lange, A E von dem Borne.   

Abstract

The presence of platelet- and neutrophil-bound immunoglobulin (PBIg and NBIg) in thrombocytopenic or neutropenic HIV-infected individuals has led to the concept that in HIV infection thrombocytopenia and neutropenia are mediated by autoimmunity. However, PBIg and NBIg were also demonstrated in non-cytopenic HIV-infected individuals. We determined the prevalence of autoantibodies against neutrophils and platelets by immunofluorescence in randomly chosen persons in different stages of asymptomatic and symptomatic HIV infection. Platelet and neutrophil autoantibodies already appeared in the asymptomatic stage and their prevalence further increased in the symptomatic stages. No correlation was found between the presence of either platelet or neutrophil antibodies and the occurrence of circulating immune complexes in the blood or the serum immunoglobulin level. There was no significant difference in neutrophil counts in HIV-infected persons with or without neutrophil autoantibodies. In addition, no significant difference in neutrophil count was found between HIV-infected and non-HIV-infected persons. HIV-infected individuals with platelet autoantibodies tended to have a lower platelet count than HIV-infected individuals without these antibodies. However, the platelet count in HIV-infected individuals without platelet antibodies was significantly lower than in the non-HIV infected persons. Thus, autoantibodies against platelets and neutrophils occur early in HIV infection and their prevalence is correlated with disease progression. Their presence is associated with cytopenia only in a limited number of persons. Non-immune mechanisms also mediate thrombocytopenia in HIV infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1974174      PMCID: PMC1535005          DOI: 10.1111/j.1365-2249.1990.tb05284.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Platelet autoantibody in a case of infectious mononucleosis presenting as thrombocytopenic purpura.

Authors:  L Ellman; A Carvalho; B M Jacobson; R W Colman
Journal:  Am J Med       Date:  1973-11       Impact factor: 4.965

2.  Interference of IgG, IgG aggregates and immune complexes in tests for platelet autoantibodies.

Authors:  F M Helmerhorst; R J Smeenk; C E Hack; C P Engelfriet; A E von dem Borne
Journal:  Br J Haematol       Date:  1983-11       Impact factor: 6.998

3.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

4.  A simple immunofluorescence test for the detection of platelet antibodies.

Authors:  A E von dem Borne; F W Verheugt; F Oosterhof; E von Riesz; A B de la Rivière; C P Engelfriet
Journal:  Br J Haematol       Date:  1978-06       Impact factor: 6.998

5.  On the mechanism of thrombocytopenic purpura in sexually active homosexual men.

Authors:  C M Walsh; M A Nardi; S Karpatkin
Journal:  N Engl J Med       Date:  1984-09-06       Impact factor: 91.245

6.  Autoimmune thrombocytopenic purpura in homosexual men.

Authors:  L Morris; A Distenfeld; E Amorosi; S Karpatkin
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

8.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

Authors:  F Barré-Sinoussi; J C Chermann; F Rey; M T Nugeyre; S Chamaret; J Gruest; C Dauguet; C Axler-Blin; F Vézinet-Brun; C Rouzioux; W Rozenbaum; L Montagnier
Journal:  Science       Date:  1983-05-20       Impact factor: 47.728

9.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

10.  Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS.

Authors:  J A Levy; A D Hoffman; S M Kramer; J A Landis; J M Shimabukuro; L S Oshiro
Journal:  Science       Date:  1984-08-24       Impact factor: 47.728

View more
  4 in total

Review 1.  Harmful and beneficial antibodies in immune thrombocytopenic purpura.

Authors:  P A Imbach
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

Review 2.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

3.  Autoantibodies to the alpha/beta T-cell receptors in human immunodeficiency virus infection: dysregulation and mimicry.

Authors:  D F Lake; S F Schluter; E Wang; R M Bernstein; A B Edmundson; J J Marchalonis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

4.  Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells.

Authors:  O Scheglovitova; V Scanio; S Fais; S Papadia; I Abbate; C Castilletti; F Dianzani; M R Capobianchi
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.